BEIJING–(BUSINESS WIRE)–InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of…
Autor: Press Room
35 years of experience in the field of communications specialized in various business areas, such as administration, marketing, writing, public relations and more.
E Ink Launches E Ink Prism™ 3, A Multi-Color ePaper Film Enabling Product Personalization
E Ink’s next generation segmented display offers a sustainable display choice for product designers BILLERICA, Mass.–(BUSINESS…
xTool D1 Pro Review (2023): Laser Engraver & Cutting Machine Review Published by Cutting Simply
BOSTON–(BUSINESS WIRE)–Cutting Simply, a leading website for laser engraver and cutting machine reviews and guides, has…
Huawei Unveils Top 10 Site Power Trends
SHENZHEN, China–(BUSINESS WIRE)–Huawei has released a white paper on the Top 10 Site Power Trends at…
Alpha Healthcare Acquisition Corp. III Announces Merger with Carmell Therapeutics, a Phase 2 Stage Biotechnology Platform Company Developing Allogeneic Plasma-based Biomaterials for Bone and Soft Tissue Healing Indications
NEW YORK & PITTSBURGH–(BUSINESS WIRE)–Alpha Healthcare Acquisition Corp. III (Nasdaq: ALPA) (“ALPA”), a special purpose acquisition…
Bitwise Announces Results of December 2022 Month-End Crypto Index Reconstitution
Intel (INTC), CBOE Global Markets (CBOE), Nu Holdings (NU), and Applied Blockchain (APLD) enter the Bitwise…
Continental and Ambarella Partner On Assisted and Automated Driving Systems With Full Software Stack
Strategic partnership: Joint development of perception solutions and full-stack systems for advanced driver assistance and highly…
Ganymed Robotics Raises Additional €15 M through Series B Extension Bringing Total Amount to €36 M
The European Innovation Council (EIC) Fund, through the EIC Accelerator Program, and Cap Horn join existing…
Trade Republic Offers 2 Percent Interest on Cash for All Customers
All customers receive 2 percent p.a. interest on their cash balance Market leading annual interest rate…
Orano Med Starts Phase I Trial With Alpha Radioligand Therapy 212Pb-GRPR in Patients With Solid Tumors
PARIS–(BUSINESS WIRE)–Orano Med, a clinical stage radiopharmaceutical company, today announced that the first patient has been…